SCARTOZZI, MARIO
 Distribuzione geografica
Continente #
NA - Nord America 58
EU - Europa 9
AS - Asia 5
Totale 72
Nazione #
US - Stati Uniti d'America 58
IT - Italia 7
HK - Hong Kong 3
DE - Germania 1
GB - Regno Unito 1
LB - Libano 1
SG - Singapore 1
Totale 72
Città #
Chicago 5
Ashburn 4
San Francisco 4
Denver 3
Los Angeles 3
New York 3
Rome 3
Seattle 3
Boardman 2
Dallas 2
Herndon 2
Noicattaro 2
Beirut 1
Buffalo 1
Cheyenne 1
Crugers 1
Dulles 1
Henderson 1
Houston 1
Las Vegas 1
Lombard 1
London 1
Nashville 1
Rochester 1
Salem 1
Santa Clara 1
Singapore 1
Totale 51
Nome #
The "angiogenetic ladder", step-wise angiogenesis inhibition in metastatic colorectal cancer, file e18b8790-3d39-d302-e053-1705fe0a27c8 10
Cetuximab rechallenge in metastatic colorectal cancer patients: How to come away from acquired resistance?, file e18b8791-e3cc-d302-e053-1705fe0a27c8 7
The correlation between LDH serum levels and clinical outcome in advanced biliary tract cancer patients treated with first line chemotherapy, file e18b8790-20d3-d302-e053-1705fe0a27c8 6
Angiogenesis genotyping in the selection of first-line treatment with either sunitinib or pazopanib for advanced renal cell carcinoma, file e18b8790-37db-d302-e053-1705fe0a27c8 5
Corrigendum: Cetuximab rechallenge in metastatic colorectal cancer patients: How to come away from acquired resistance? [Ann Oncol, 23, 9, (2012) (2313-2318)] doi: 10.1093/annonc/mdr623, file e18b8791-e3ca-d302-e053-1705fe0a27c8 5
Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in clear cell renal cell carcinoma patients, file e18b878f-df4a-d302-e053-1705fe0a27c8 4
Prognostic Value for Incidental Antihypertensive Therapy With β-Blockers in Metastatic Colorectal Cancer, file e18b8790-3363-d302-e053-1705fe0a27c8 4
Lactate Dehydrogenase in Hepatocellular Carcinoma: Something Old, Something New, file e18b8790-4775-d302-e053-1705fe0a27c8 4
VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib, file e18b878f-e21f-d302-e053-1705fe0a27c8 3
Prognostic clinical factors in pretreated colorectal cancer patients receiving regorafenib: Implications for clinical management, file e18b8790-2189-d302-e053-1705fe0a27c8 3
Prognostic impact of mismatch repair genes germline defects in colorectal cancer patients: Are all mutations equal?, file e18b8790-218b-d302-e053-1705fe0a27c8 3
Three drugs vs two drugs first-line chemotherapy regimen in advanced gastric cancer patients: a retrospective analysis, file e18b8790-3230-d302-e053-1705fe0a27c8 3
Tracking the 2015 gastrointestinal cancers symposium: Bridging cancer biology to clinical gastrointestinal oncology, file e18b8790-3365-d302-e053-1705fe0a27c8 3
The role of micro-RNAs in hepatocellular carcinoma: from molecular biology to treatment, file e18b8790-3d3a-d302-e053-1705fe0a27c8 3
Off-target effects and clinical outcome in metastatic colorectal cancer patients receiving regorafenib: The TRIBUTE analysis, file e18b8790-8c46-d302-e053-1705fe0a27c8 3
The Role of p53 Expression in Patients with RAS/BRAF Wild-Type Metastatic Colorectal Cancer Receiving Irinotecan and Cetuximab as Later Line Treatment, file e18b8791-f2af-d302-e053-1705fe0a27c8 3
Liquid Biopsy-Driven Cetuximab Rechallenge Strategy in Molecularly Selected Metastatic Colorectal Cancer Patients, file e18b8791-fc97-d302-e053-1705fe0a27c8 3
Totale 72
Categoria #
all - tutte 743
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 743


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221 0 0 0 0 0 0 0 0 0 0 0 1
2022/202371 18 1 5 17 2 4 5 15 2 0 2 0
Totale 72